ePRO Resources
-
3 Steps To Improve Site Acceptance Of ePRO In Medical Device Trials
3/6/2023
Discover how with the proper understanding of a site’s barriers, early engagement, and prioritizing effective training, site acceptance of ePRO can be improved.
-
Paying Sites To Reduce Burden
6/12/2026
Beth Harper and Rosie Filling discuss site burden, enrollment pressure, and why sponsors should help pay for technology and training.
-
Ensuring Patient-Centered Care In Oncology Trials
11/10/2023
In oncology trials, safety and tolerability are a core focus. From centralized ECGs to patient-reported outcomes, utilize this guide for optimizing assessments of drug safety and quality of life.
-
Rare Disease Clinical Trials: Modern Design And Supply Chain
10/12/2023
Gain insight from several contributing experts for overcoming unique obstacles in rare disease research and learn how to better develop strategies.
-
Gain The ePRO Advantage With Real-Time Data Collection
12/2/2022
Discover how ePRO automatically incorporates eCOA data into a study, improving the depth, timeliness, and accuracy of patient-reported outcomes data in the following ways.
-
Why Site Burden Goes Beyond eSource
6/12/2026
Beth Harper explains why the real problem is broader than eSource and why sponsors should integrate around the systems sites already use.
-
Site Tech, Integration, And Reducing Burden
6/12/2026
Beth Harper, Rosie Filling, and Joe Dustin discuss site tech, integration, and how sponsors can reduce burden while improving flow.
-
Nevro Eliminates Majority Of Source Data Verification With ePRO And EDC
2/23/2023
Read how a global medical device company was able to unlock new efficiencies by implementing data collection via electronic patient-reported outcome assessments.
-
ePRO's Impact On Patient And Site Journeys
5/15/2024
Join our solutions experts as they demonstrate how Castor ePRO can enhance your clinical trial by improving the patient experience and streamlining site operations.
-
Increasing The Usefulness Of PROs In Oncology Research
2/20/2024
Dr. Anthony Everhart (Clinical VP, Signant Health) and Tim Meyer (Professor, University College London) discuss opportunities for increasing the usefulness of PROMs.